Literature DB >> 8233428

Histocompatibility antigens and geographic tongue.

A Fenerli1, S Papanicolaou, M Papanicolaou, G Laskaris.   

Abstract

The HLA-A, B and HLA-DR antigens were investigated in 50 unrelated Greek persons with geographic tongue and in 380 healthy control persons. An increased incidence of DR5 and DRW6 antigens was observed in the blood of persons with geographic tongue. Ten (20%) of them had the DRW6 antigen, and it was significantly increased compared with 29 (7.6%) of the controls (p < 0.01, RR = 3.32). Twenty-seven (54%) of the experimental group showed DR5 antigen compared with 136 (35.7%) of the controls (p < 0.025, RR = 2.18). On the contrary, only 12% (5) of the experimental group had the B51 antigen in comparison with the controls (26.3%) (p < 0.05, RR = 0.37). A decrease of the DR2 antigen was also found in the persons with geographic tongue (24%) in comparison with the controls (39.2%) (p < 0.05, RR = 0.58).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233428     DOI: 10.1016/0030-4220(93)90015-v

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  3 in total

Review 1.  Paediatric Geographic Tongue: A Case Report, Review and Recent Updates.

Authors:  Doddabasavaiah Basavapur Nandini; Shivanand Bagalad Bhavana; Byathnal Suryakanth Deepak; Ramakrishna Ashwini
Journal:  J Clin Diagn Res       Date:  2016-02-01

2.  GEOGRAPHIC TONGUE: PATTERN OF PRESENTATION IN A SOUTH WESTERN NIGERIAN TEACHING HOSPITAL.

Authors:  E O Oyetola; A Oluwande; E T Agho
Journal:  Ann Ib Postgrad Med       Date:  2018-12

Review 3.  Geographic tongue and psoriasis: clinical, histopathological, immunohistochemical and genetic correlation - a literature review.

Authors:  Bruna Lavinas Sayed Picciani; Tábata Alves Domingos; Thays Teixeira-Souza; Vanessa de Carla Batista Dos Santos; Heron Fernando de Sousa Gonzaga; Juliana Cardoso-Oliveira; Alexandre Carlos Gripp; Eliane Pedra Dias; Sueli Carneiro
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.